| View |
|
DRP-13151-04
|
Hydrocortisone (as sodium succinate)
|
Hydroclear
|
100 mg
|
Powder for Injection (I.M./I.V.)
|
Corticosteroid for Systemic Use (Glucocorticoid)
|
Skymap Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
03 December 2023
|
12 December 2027
|
| View |
|
DRP-13156-01
|
Pioglitazone (as hydrochloride)
|
Goglitazone-15
|
15mg
|
Tablet
|
Antidiabetic Agent (Thiazolidinedione)
|
Ind-Swift Limited
|
India
|
CLIDP Conversion
|
13 December 2023
|
12 December 2027
|
| View |
|
DRP-13229-07
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Azentin
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
05 December 2023
|
05 January 2028
|
| View |
|
DRP-13229-08
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Sitakem-M
|
50 mg/ 500 mg
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Magbro Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
14 December 2023
|
05 January 2028
|
| View |
|
DRP-13249-05
|
Hydrocortisone (as sodium succinate)
|
None
|
100 mg
|
Powder for Injection (I.M./I.V.)
|
Corticosteroid (Glucocorticoid)
|
United Biotech Pvt. Ltd
|
India
|
CLIDP Conversion
|
24 November 2023
|
10 January 2028
|
| View |
|
DRP-13365-01
|
Imatinib (as mesylate)
|
Kemtinib
|
100 mg
|
Film-Coated Tablet
|
Protein-Tyrosine Kinase Inhibitor
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
03 December 2023
|
07 February 2028
|
| View |
|
DRP-13374-01
|
Moxifloxacin (as hydrochloride)
|
Moxflakem
|
5 mg / mL (0.5 % w/v)
|
Ophthalmic Solution
|
Antibacterial (Fluoroquinolone)
|
Beximco Pharmaceuticals Ltd.
|
Bangladesh
|
CLIDP Conversion
|
14 December 2023
|
08 February 2028
|
| View |
|
DRP-13473-01
|
Pioglitazone (as hydrochloride)
|
Goglitazone 30
|
30 mg
|
Tablet
|
Oral Hypoglycemic
|
Ind-Swift Limited
|
India
|
CLIDP Conversion
|
13 December 2023
|
27 February 2028
|
| View |
|
DRP-13512
|
Thiamine Nitrate (Vitamins B1) + Pyridoxine Hydrochloride (Vitamin B6) + Cyanocobalamin (Vitamin B12)
|
None
|
Each capsule contains:
Thiamine Nitrate (Vitamins B1) 300 mg
Pyridoxine Hydrochloride (Vitamin B6) 100 mg
Cyanocobalamin (Vitamin B12) 100 mcg
|
Capsule
|
Vitamin
|
Pharmatechnica Laboratory Inc
|
Philippines
|
Automatic Renewal (OTC)
|
03 December 2023
|
09 January 2029
|
| View |
|
DRP-13570-01
|
Rivaroxaban
|
None
|
20 mg
|
Film-Coated Tablet
|
Anticoagulant
|
Bayer AG
|
Germany
|
CLIDP Conversion
|
14 December 2023
|
25 April 2025
|
| View |
|
DRP-13620-01
|
Losartan potassium + Amlodipine (as besilate)
|
Cardea
|
50 mg/5 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker/Calcium Channel Blocker
|
Globela Pharma Private Limited
|
India
|
CLIDP Conversion
|
09 December 2023
|
21 March 2028
|
| View |
|
DRP-13712-02
|
Moxifloxacin (as hydrochloride) + Dexamethasone Phosphate (as sodium)
|
Aguamox
|
5 mg/1 mg per mL (0.5% w/v / 0.1% w/v)
|
Ophthalmic Solution
|
Anti-infective (Fluoroquinolone) / Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
13 December 2023
|
30 March 2028
|
| View |
|
DRP-13712-04
|
Moxifloxacin (as hydrochloride) + Dexamethasone phosphate (as sodium)
|
Moxidex
|
5 mg / 1 mg per mL (0.5 % w/v / 0.1 % w/v)
|
Ophthalmic Solution
|
Anti-infective (Fluoroquinolone)/ Corticosteroid
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
14 December 2023
|
30 March 2028
|
| View |
|
DRP-13778
|
Losartan Potassium
|
Lanzaar 50
|
50 mg
|
Film-Coated Tablet
|
Angiotensin II Receptor Blocker
|
Berlin Pharmaceutical Industry Co., Ltd.
|
Thailand
|
Automatic Renewal
|
06 December 2023
|
18 February 2029
|
| View |
|
DRP-13946-01
|
Leuprorelin Acetate
|
Leustar
|
3.75 mg
|
Powder for Injection (IM/SC)
|
Gonadotropin Releasing Hormone Analog
|
Dongkook Pharmaceutical Co., Ltd
|
Korea
|
CLIDP Conversion
|
13 December 2023
|
23 May 2028
|
| View |
|
DRP-13963-01
|
Cefepime (as hydrochloride)
|
None
|
2 g
|
Powder for Injection (IM/IV)
|
Antibacterial (Cephalosporin)
|
PT Darya-Varia Laboratoria Tbk
|
Indonesia
|
CLIDP Conversion
|
26 November 2023
|
14 March 2028
|
| View |
DRP-14066-01_PI_01.pdf
|
DRP-14066-01
|
Vildagliptin
|
Vildus
|
50 mg
|
Tablet
|
Dipeptidyl peptidase 4 (DPP-4) Inhibitor
|
Lee Pharma Limited
|
India
|
CLIDP Conversion
|
03 December 2023
|
13 June 2028
|
| View |
|
DRP-14374-01
|
Cilostazol
|
None
|
50 mg
|
Tablet
|
Antithrombotic Agent (Platelet aggregation inhibitor)
|
Cooper Pharma Limited
|
India
|
CLIDP Conversion
|
03 December 2023
|
30 August 2028
|
| View |
|
DRP-14375-01
|
Dutasteride + Tamsulosin hydrochloride
|
Tamulsin Plus
|
500 mcg / 400 mcg
|
Capsule
|
Benign Prostatic Hypertrophy Drug (Alpha-adrenoreceptor antagonist)
|
Pell Tech Health Care Private Ltd.
|
India
|
CLIDP Conversion
|
03 December 2023
|
31 August 2028
|
| View |
|
DRP-1677-09
|
Folic Acid
|
Unbranded
|
5 mg
|
Table
|
Hematinic
|
Hizon Laboratories, Inc.
|
Philippines
|
Renewal
|
18 May 2024
|
16 July 2029
|